Compendium of Cancer Genome Aberrations

CNS5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
Editor updated for a page on volunteer assignments
 
(12 intermediate revisions by 3 users not shown)
Line 19: Line 19:
|-
|-
|
|
==== CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS) ====
====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)====
|
|
----
----
Line 44: Line 44:
|6/25/2023
|6/25/2023
|
|
|PENDING
|COMPLETE
|
|
|Laveniya Satgunaseelan (LS)
|Laveniya Satgunaseelan (LS)
Line 52: Line 52:
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|Riley Lochner (trainee);
Shashi Shetty (mentor)
|6/7/2022
|6/7/2022
|
|
Line 63: Line 64:
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|Disease
|Disease
|Meenakshi Mehrotra
|Jieying Wu
|
|11/18/2025
|
|01/15/2026
|PENDING
|PENDING
|
|
Line 110: Line 111:
|5/3/2024
|5/3/2024
|
|
|PENDING
|PENDING - email reminder 9/4/2025
|
|
|LS
|LS
Line 118: Line 119:
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|Disease
|Disease
|Laveniya Satgunaseelan (Linda Cooley - previous version)
|Laveniya Satgunaseelan
|
|
|
|12/06/2025
|PENDING
|PENDING
|
|
Line 173: Line 174:
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|Disease
|Disease
|Jeremy Pulvers
|9/13/2022<br />
|
|
|PENDING
|<br />
|
|
|
|
|LS
|LS
Line 195: Line 196:
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|Disease
|Disease
|Wahab Khan
|15/04/2025
|
|
|
|PENDING - email reminder 9/4/2025
|
|
|
|
|LS
|LS
Line 338: Line 339:
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|Disease
|Disease
|Laveniya Satgunaseelan
|9/11/2024
|
|
|
|COMPLETE
|
|8/7/2025
|
|LS
|
|LS
|
|Used for testing 9/2024 somatic template
|
|
|-
|-
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
Line 535: Line 536:
|-
|-
|
|
==== CHAPTER 3 (CHOROID PLEXUS TUMOURS) ====
====CHAPTER 3 (CHOROID PLEXUS TUMOURS)====
|
|
----
----
Line 589: Line 590:
|-
|-
|
|
==== CHAPTER 4 (EMBRYONAL TUMOURS) ====
====CHAPTER 4 (EMBRYONAL TUMOURS)====
|
|
----
----
Line 611: Line 612:
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Disease
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|Lisa Lansdon, PhD (LGG trainee just finished);
Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|9/20/21
|
|
Line 633: Line 635:
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|Disease
|Hannah Wollenzien
|1/11/2026
|
|
|Pending
|
|
|
|MS
|
|
|
|
|
|
|
Line 742: Line 744:
|-
|-
|
|
==== CHAPTER 5 (PINEAL TUMOURS) ====
====CHAPTER 5 (PINEAL TUMOURS)====
|
|
----
----
Line 797: Line 799:
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|Disease
|Fang Fang (trainee)+Katie Schieffer (mentor)
|11/19/2025
|5/15/2026
|Pending
|
|
|
|LS
|
|
|
|
|
|
|
|
Line 829: Line 831:
|-
|-
|
|
==== CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS) ====
====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)====
|
|
----
----
Line 938: Line 940:
|-
|-
|
|
==== CHAPTER 7 (MENINGIOMA) ====
====CHAPTER 7 (MENINGIOMA)====
|
|
----
----
Line 970: Line 972:
|-
|-
|
|
==== CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS) ====
====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)====
|
|
----
----
Line 1,123: Line 1,125:
|-
|-
|
|
==== CHAPTER 9 (MELANOCYTIC TUMOURS) ====
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
|
|
----
----
Line 1,166: Line 1,168:
|-
|-
|
|
==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS) ====
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
|
|
----
----
Line 1,352: Line 1,354:
|-
|-
|
|
==== CHAPTER 11 (GERM CELL TUMOURS) ====
====CHAPTER 11 (GERM CELL TUMOURS)====
|
|
----
----
Line 1,384: Line 1,386:
|-
|-
|
|
==== CHAPTER 12 (TUMOURS OF THE SELLAR REGION ====
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
|
|
----
----
Line 1,471: Line 1,473:
|-
|-
|
|
==== CHAPTER 13 (METASTASES TO THE CNS) ====
====CHAPTER 13 (METASTASES TO THE CNS)====
|
|
----
----
Line 1,514: Line 1,516:
|-
|-
|
|
==== CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS) ====
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
|
|
----
----
Retrieved from "https://test.ccga.io/index.php/CNS5:Volunteer_Assignments_and_Opportunities"